Wednesday, February 10, 2021
Ractigen Therapeutics closes on $17 Million Series A to advance lead program into clinical phase, led by Hillhouse Venture Capital
[2/11/2021, Nantong] Ractigen Therapeutics, a leading company in the saRNA drug space, announced that it has closed a 17$ million USD (￥110 million) Series A financing round led by Hillhouse Venture Capital with participation from CCB Healthcare Growth Fund, Boyi Capital, and Longman Capital to support advancement of its lead ph
Tuesday, May 19, 2020
CB Insights lists Ractigen as one of the Top RNA biotech companies in China
[May 19th, 2020] Today, CB Insights China published, for the first time, a top list of RNA biotech companies in China and Ractigen Therapeutics, as the only company developing RNAa therapeutics, is listed as top 3.
Wednesday, July 11, 2018
Delegation from Nantong University Medical School visits Ractigen
[July 11, 2018] Today, a 5-member delegation, led by the dean Professor Fei Sun, from Nantong University Medical School paid a visit to Ractigen and Rudong Life and Health Industry Park.
Wednesday, February 7, 2018
Scientists from Ractigen and KRIBB publish new study on saRNA-guided activation of VHL gene in renal cell carcinoma
Wednesday, October 11, 2017
Ractigen Therapeutics CSO Dr. Robert Place delivers a keynote speech at the 6th RNAi China conference
The 6th RNAi China conference was held on October 10th and 11th at Kunshan as expected. A host of leading experts in the fields of oligonucleotide research and drug development from both academia and industry including Ractigen Therapeutics’s CEO Dr.
Sunday, June 18, 2017
Ractigen Therapeutics officially opens its door for business
[Rudong, China] The grand opening ceremony of Ractigen Therapeutics took place on the morning of June 18th, 2017 in front of Ractigen’s building in the Life-Health Industrial Park, Rudong, Jiangsu.
Wednesday, July 12, 2017
The first book on RNAa published
Springer•Nature published a book edited by Ractigen’s founder, Dr. Long-Cheng LI and entitled “RNA Activation”. This is the first published book on RNAa and was contributed by over 40 worldwide experts working on RNAa.
Sunday, April 30, 2017
HS Talk published a lecture presented by Ractigen’s co-founder and CEO, Dr. Long-Cheng Li
Henry Stewart Talks which publishes animated audio visual presentations by world leading experts published a lecture by Dr. Long-Cheng Li.
Friday, September 2, 2016
Ractigen Therapeutics officially incorporated
On September 2, 2016, Ractigen Therapeutics was officially incorporated and registered with the Industry and Commerce Bureau of Nantong, Jiangsu Province.